BiotechTube
Home/Vyripharm Biopharmaceuticals/Elias Jackson Jr., Ph.D.
EJ

Elias Jackson Jr., Ph.D.

Director of Government and Scientific Affairs

Vyripharm Biopharmaceuticals

Therapeutic Areas

OncologyInfectious DiseaseNeurological Disorders

Vyripharm Biopharmaceuticals Pipeline

DrugIndicationPhase
VYR-206Neurological Disorders (Diagnostic)Pre-clinical
Antiviral Theranostic ProgramCOVID-19 / Viral InfectionsPre-clinical
Oncology ProgramsOncologyPre-clinical
Hemp/Cannabis StandardizationAgribiopharmaceuticals Testing/ClassificationResearch

Leadership Team at Vyripharm Biopharmaceuticals

PC
Phil Clarke
Chief Business Officer
EP
Eddie Patton Jr., M.D.
Chief Medical Officer
View full Vyripharm Biopharmaceuticals profile